L Turecký
-
- Metabolism and Genetic Disorders 4
-
- Diet, Metabolism, and Disease 5
-
- Liver Disease Diagnosis and Treatment 11
- Microscopic Colitis 3
-
- Drug-Induced Hepatotoxicity and Protection 4
-
- Inflammatory Bowel Disease 4
-
- Computational Drug Discovery Methods 3
-
- Trace Elements in Health 2
L Turecký
35 papers receiving 408 citations
Peers
Comparison fields: 5 of 84
- Hepatology 40
- Clinical Biochemistry 31
- Endocrinology, Diabetes and Metabolism 55
- Epidemiology 114
- Pathology and Forensic Medicine 58
Countries citing papers authored by L Turecký
This map shows the geographic impact of L Turecký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Turecký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Turecký more than expected).
Fields of papers citing papers by L Turecký
This network shows the impact of papers produced by L Turecký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Turecký. The network helps show where L Turecký may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L Turecký, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 9 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 11 | |
| 4 | 2018 | 7 | |
| 5 | 2018 | 19 | |
| 6 | 2018 | 8 | |
| 7 | 2017 | 2 | |
| 8 | Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients. | 2016 | 8 |
| 9 | 2012 | 7 | |
| 10 | 2010 | 6 | |
| 11 | Plasma copper and ceruloplasmin in patients with alcoholic liver steatosis. | 2008 | 14 |
| 12 | Serum cholinesterase activity and proteosynthetic function of liver in patients with diabetes mellitus. | 2005 | 16 |
| 13 | 2003 | 16 | |
| 14 | 2003 | 4 | |
| 15 | Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor alpha antibody (infliximab) in Crohn's disease. | 2003 | 6 |
| 16 | 1997 | 43 | |
| 17 | [Plasma proteins in patients with liver steatosis and the effect of treatment of essential phospholipids]. | 1996 | 1 |
| 18 | 1994 | 9 | |
| 19 | [Therapeutic effect of silymarin in patients with liver cirrhosis]. | 1987 | 2 |
| 20 | 1984 | 72 |
About L Turecký
L Turecký is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 36 papers that have together received 423 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (5 papers), Metabolism and Genetic Disorders (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Inflammatory Bowel Disease (4 papers), Computational Drug Discovery Methods (3 papers), Microscopic Colitis (3 papers) and Trace Elements in Health (2 papers). The work is most often cited by research in Hepatology (40 citations), Clinical Biochemistry (31 citations) and Endocrinology, Diabetes and Metabolism (55 citations). L Turecký has collaborated with scholars based in Slovakia and Czechia. Frequent co-authors include Viera Kupčová, Peter Kalina, T Ravíngerová, Iveta Waczulı́ková, J Čársky, Katarı́na Volkovová, A Ziegelhöffer, A Dzurba, Albert Breier and J Styk. Their work appears in journals such as Journal of Neurochemistry, International Journal of Environmental Research and Public Health and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.